美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

康休

65.60

+0.0000

成交量：- -

成交額：- -

市值：127.60億

市盈率：-1.26

高：65.60

開：65.60

低：65.60

收：65.60

資料載入中...

總覽公司新聞公告

逢高賣股，大賺超20億！藥明康德反彈超2%！CXO集體跟漲，醫療ETF（512170）盤中漲超1.6%

興業證券：觸底回升、拐點已現 CXO行業供需格局改善催化新一輪上升週期

中金公司：生物醫藥穩健紅利基本盤關注創新與出海

北信瑞豐龐文傑：生物醫藥投融資回暖，CXO行業拐點已至

美國生物安全法案“擱淺”“藥明系”CXO企業成功上岸了嗎？

【券商聚焦】浦銀國際對2025年醫藥板塊整體呈樂觀態度看好創新藥、醫療器械及CXO

《生物安全法案》“搭便車”NDAA失敗，國內CXO板塊迎反彈

每日经济新闻

美生物安全法案未納入NDAA，CXO巨頭藥明康德飆升逾7.5%！醫療ETF（512170）漲超1%衝擊三連陽

港股概念追蹤|生物安全法案未被列入NDAA最新版本機構看好CXO板塊底部機會（附概念股）

【券商聚焦】中信建投指長期看好CXO板塊發展潛力及成長空間

中信建投：長期仍舊看好CXO板塊發展潛力及成長空間

每日经济新闻

久旱逢甘霖！CXO大舉反攻，醫療器械同步活躍，醫療ETF（512170）單週累漲3.23%，大幅跑贏市場！

【觀察】CXO龍頭漲超9%，美國生物安全法案妥協了？

【港股收評】三大指數齊走高，恆科漲超2%！CXO成“領漲先鋒”

港股收盤，恒指收漲1.56%，科指收漲2.16%。CXO概念股走勢強勁，藥明康德(02359.HK)收漲約9%，藥明生物

醫療大反攻！CXO集體飆升，巨頭藥明康德漲逾8%，醫療ETF（512170）放量摸高4%！

港股午評：恒生指數漲1.4%，恒生科技指數漲1.72%

A股午評：滬指放量漲1.23% 保險股大漲

港股CXO概念股震盪走高，藥明康德漲超5%

每日经济新闻

【券商聚焦】西南證券指CXO行業收入逐季回升板塊悲觀預期修復在即

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CXO/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CXO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CXO\",,,,,undefined,":{"symbol":"CXO","market":"US","secType":"STK","nameCN":"康休","latestPrice":65.6,"timestamp":1610744400000,"preClose":65.6,"halted":4,"volume":0,"delay":0,"floatShares":192489259,"shares":194506801,"eps":-52.266872,"marketStatus":"退市","change":0,"latestTime":"01-15 16:00:00 EST","open":65.6,"high":65.6,"low":65.6,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-52.266872,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1744790400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1186113600000,"exchange":"NYSE","adjPreClose":65.6,"dividendRate":0.011052,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CXO\",,,,,undefined,":{"symbol":"CXO","floatShares":192489259,"roa":"-30.69%","roe":"-77.91%","lyrEps":-3.548023,"shares":194506801,"dividePrice":0.725,"high":65.6,"amplitude":0,"preClose":65.6,"low":65.6,"week52Low":33.13,"pbRate":"1.64","week52High":90.52,"institutionHeld":0,"latestPrice":65.6,"eps":-52.266872,"divideRate":0.011052,"volume":0,"delay":0,"ttmEps":-52.266872,"open":65.6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CXO\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2503392567","title":"逢高賣股，大賺超20億！藥明康德反彈超2%！CXO集體跟漲，醫療ETF（512170）盤中漲超1.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503392567","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503392567?lang=zh_tw&edition=fundamental","pubTime":"2025-01-14 10:13","pubTimestamp":1736820780,"startTime":"0","endTime":"0","summary":"1月14日早盘，医疗板块连续第2日反弹，AI医疗概念股卫宁健康大涨超3%居首，CXO龙头股强势表现，药明康德、康龙化成、昭衍新药集体涨超2%。　　场内ETF方面，医疗ETF被动跟踪中证医疗指数，早盘高开高走，截至发稿涨1.64%，成交额超1.3亿元。资金面上，截至前一日，医疗ETF近10日累计吸金6.37亿元，近20日累计获超12.58亿元净申购。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-01-14/doc-ineexcef8921359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02359","603259","LU0456842615.SGD","LU2242644610.SGD","CXO","LU0052750758.USD","LU1997245177.USD","159828","BK1576","LU0708995583.HKD","BK1141","512170","BK1583","LU1046422090.SGD","LU2045819591.USD","LU0320764599.SGD","LU2125910500.SGD","BK0216","LU1997245094.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2501412308","title":"興業證券：觸底回升、拐點已現 CXO行業供需格局改善催化新一輪上升週期","url":"https://stock-news.laohu8.com/highlight/detail?id=2501412308","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501412308?lang=zh_tw&edition=fundamental","pubTime":"2025-01-05 21:57","pubTimestamp":1736085447,"startTime":"0","endTime":"0","summary":"当前建议关注海外业务为主、需求订单回暖、经营指标出现拐点，以及多肽ADC等高景气度赛道的CXO公司。2024年以来全球生物医药投融资明显改善，部分国内头部CXO公司新签订单开始回暖，行业需求端改善将逐渐传导至业绩端，CXO板块2025年业绩复苏值得期待。目前CXO行业正处于周期拐点，供给端产能正在出清，未来产能利用率有望触底回升，供需关系改善催化CXO行业进入上升周期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1233523.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0276","BK0028","BK0012","CXO","BK0188","601377","BK0183"],"gpt_icon":0},{"id":"2495689517","title":"中金公司：生物醫藥穩健紅利基本盤 關注創新與出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2495689517","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495689517?lang=zh_tw&edition=fundamental","pubTime":"2024-12-31 09:13","pubTimestamp":1735607589,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["399441","BK0276","159992","BK1100","SG9999002828.SGD","BK1515","BK1516","BK1191","159938","09939","BK1564","CXO","BK1574","161726","03908","159883","06978","BK1161","CXO.AU","09997","09996","BK1501","601995","BK1583","BK7504","BK1147","01477","BK1222","159891","BK7095"],"gpt_icon":0},{"id":"2492711972","title":"北信瑞豐龐文傑：生物醫藥投融資回暖，CXO行業拐點已至","url":"https://stock-news.laohu8.com/highlight/detail?id=2492711972","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492711972?lang=zh_tw&edition=fundamental","pubTime":"2024-12-18 17:11","pubTimestamp":1734513060,"startTime":"0","endTime":"0","summary":"最近，生物医药企业赴港上市也越来越多，A+H两地发行成了上市药企的新选择；未盈利药企定向增发再融资也有了成功过会先例；生物医药领域的并购重组也日渐增多。国内创新药投融资渠道正在逐渐打开。新一轮生物医药创新周期，国内产业界和资本正在迎头赶上。作为创新药研发的买水人，CXO行业将在这新一轮周期中持续受益。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjsy/2024-12-18/doc-inczwpwv7780552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["399441","CXO","161726"],"gpt_icon":0},{"id":"2491580729","title":"美國生物安全法案“擱淺”“藥明系”CXO企業成功上岸了嗎？","url":"https://stock-news.laohu8.com/highlight/detail?id=2491580729","media":"投资者网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491580729?lang=zh_tw&edition=fundamental","pubTime":"2024-12-14 08:05","pubTimestamp":1734134705,"startTime":"0","endTime":"0","summary":"药明系正在转向。《投资者网》韩宜珈纠缠了“药明系”一年多的美国生物安全法案，终于有了新的进展。　美国当地时间2024年12月7日，国会参众两院军事委员会公布了2025财年国防授权法案（NDAA）最终协议文本，该版本兼顾了众议院以及参议院两方的提案。NDAA最新版本显示，生物安全法案未被列入其中。按照流程，该版本要获得...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OMwUdhdUS8O4NY20yjjpICHHkX_PsSh0UVqb-UidIQSqgAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OMwUdhdUS8O4NY20yjjpICHHkX_PsSh0UVqb-UidIQSqgAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241214A01BA100","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241214A01BA100","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["CXO"],"gpt_icon":0},{"id":"2490879827","title":"【券商聚焦】浦銀國際對2025年醫藥板塊整體呈樂觀態度 看好創新藥、醫療器械及CXO","url":"https://stock-news.laohu8.com/highlight/detail?id=2490879827","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490879827?lang=zh_tw&edition=fundamental","pubTime":"2024-12-12 15:52","pubTimestamp":1733989962,"startTime":"0","endTime":"0","summary":"2)医疗器械：看好创新高值耗材、医疗设备板块。康诺亚核心产品CM310将于2025年迎来首个完整年度商业化，作为首个国产重磅IL4R，该行认为其市场潜力巨大。此外，康诺亚研发实力强劲，NewCo形式有助于加快其出海步伐，2025年潜在出海交易有望进一步提振股票行情。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1949533","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359202008.SGD","BK1610","LU0819121731.USD","LU0417516738.SGD","BK1589","CXO","IE00B5MMRT66.SGD","159938","LU0856984785.SGD","09996","LU0516422366.SGD","159883","LU2045819591.USD","LU2125910500.SGD","LU0348735423.USD","LU1720050803.USD","LU0196878994.USD","09926","LU0307460666.USD","LU2488822045.USD","02268","LU0979878070.USD","01789","BK1141","06160","SG9999014674.SGD","06978","159992","BK1191","LU0348784397.USD","00013","LU0327786744.USD","09997","LU0043850808.USD","BK1521","LU0572944931.SGD","02269","03759","02162","LU2328871848.SGD","SG9999002562.SGD","09939","BK1100","LU0181495838.USD","02190","02359","IE00B543WZ88.USD","LU0823426308.USD","SG9999002463.SGD","06990"],"gpt_icon":1},{"id":"2490301723","title":"《生物安全法案》“搭便車”NDAA失敗，國內CXO板塊迎反彈","url":"https://stock-news.laohu8.com/highlight/detail?id=2490301723","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490301723?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 19:22","pubTimestamp":1733743341,"startTime":"0","endTime":"0","summary":"每经记者：许立波&nbsp;&nbsp;&nbsp;&nbsp;每经编辑：杨夏当地时间12月7日，美国国会参众两院军事委员会公布了2025财年国防授权法案（以下简称“NDAA”）最终协议文本，该版本兼顾了众议院以及参议院两方的提案。NDAA最新版本显示，《生物安全法案》未被列入其中，意味着《生物安全法案》通过“夹带”进NDAA进而实现立法的...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OVeLbzmbNy8zvfEv4R_rJMi0rf7KWPkL8gZp0PEHwB5W4AA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OVeLbzmbNy8zvfEv4R_rJMi0rf7KWPkL8gZp0PEHwB5W4AA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241209A08E2000","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241209A08E2000","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["CXO","NDAA"],"gpt_icon":0},{"id":"2490959507","title":"美生物安全法案未納入NDAA，CXO巨頭藥明康德飆升逾7.5%！醫療ETF（512170）漲超1%衝擊三連陽","url":"https://stock-news.laohu8.com/highlight/detail?id=2490959507","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490959507?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 10:49","pubTimestamp":1733712540,"startTime":"0","endTime":"0","summary":"海外利空解除，9日早盘，巨头药明康德跳空高开逾8%后维持高位，现涨超7.5%，领涨50只中证医疗成份股！九州药业、凯莱英、康龙化成等CXO概念股纷纷跟涨。　　267亿体量顶流医疗ETF高开近2%，现涨逾1%。　　消息面上，美国当地时间2024年12月7日，美国国会参众两院军事委员会公布了2025财年国防授权法案最终协议文本，该版本兼顾了众议院以及参议院两方的提案。NDAA最新版本显示，生物安全法案未被列入其中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2024-12-09/doc-incyvnxt2953829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2242644610.SGD","LU2125910500.SGD","BK0216","CXO","NDAA","02359","BK1141","159828","LU1046422090.SGD","LU0456842615.SGD","LU0708995583.HKD","BK1576","BK1583","603259","LU1997245177.USD","LU0052750758.USD","LU2488822045.USD","LU2045819591.USD","LU0320764599.SGD","LU1997245094.SGD","512170"],"gpt_icon":0},{"id":"2490901767","title":"港股概念追蹤|生物安全法案未被列入NDAA最新版本   機構看好CXO板塊底部機會（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2490901767","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490901767?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 09:29","pubTimestamp":1733707775,"startTime":"0","endTime":"0","summary":"美国当地时间2024年12月7日，美国国会参众两院军事委员会公布了2025财年国防授权法案最终协议文本，该版本兼顾了众议院以及参议院两方的提案。NDAA最新版本显示，生物安全法案未被列入其中。当地时间12月5日， 专注于生物制药行业的美国新闻媒体Endpoints报道，消息人士称，立法者正在考虑对针对生物安全法案的立法进行妥协，该立法将增加行政部门的审查，而不是直接禁止生物制药公司与中国公司合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0856984785.SGD","LU1794554557.SGD","LU1242518857.USD","LU1242518931.SGD","02359","CXO","LU0516423091.SGD","LU0588546209.SGD","BK1583","LU0359202008.SGD","LU0140636845.USD","BK1141","NDAA","LU2242644610.SGD","02269","LU2125910500.SGD","LU0181495838.USD","06821","LU0708995583.HKD","LU1720050803.USD","LU2045819591.USD","LU0039217434.USD","LU0516422440.USD","LU0516423174.USD","LU0823426480.USD","HSTECH","LU0052750758.USD","LU0417516738.SGD","LU0456827905.SGD","LU0979878070.USD","LU0051755006.USD","07226","BK1610","LU0348825331.USD","LU0572944931.SGD","LU1046422090.SGD","LU2039709279.SGD","LU0359201612.USD","BK1589","LU0417516902.SGD","HSCEI","BK1521","BK1191","LU0043850808.USD","LU0307460666.USD","YANG","LU0348735423.USD","LU1880383366.USD","LU0516422366.SGD","BK1576"],"gpt_icon":1},{"id":"2490648317","title":"【券商聚焦】中信建投指長期看好CXO板塊發展潛力及成長空間","url":"https://stock-news.laohu8.com/highlight/detail?id=2490648317","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490648317?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 08:59","pubTimestamp":1733705972,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投发研报指，23年底以来海外投融资逐渐恢复，下游需求维持向好，国内投融资底部趋稳，下游需求仍有待恢复。受益于国内CXO产业链的全面以及竞争力的领先，行业受地缘政治影响目前较为有限。国内临床前及临床CRO价格趋稳，经营趋势有望逐渐向上。CDMO企业商业化需求稳定，大订单影响24Q4开始已经消除。近年来在ADC、多肽药物快速发展下，相关CXO需求迅速增加，小核酸、CGT等细分领域也有望迎来快速发展。长期来看，仍旧看好CXO板块发展潜力及成长空间。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/YjEwODMyZjRkNWI4NjVjNzFhNGY4NWE0ZDExNzMxMDU0NzE5MDIz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjEwODMyZjRkNWI4NjVjNzFhNGY4NWE0ZDExNzMxMDU0NzE5MDIz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1949187","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CXO","601066","BK0276"],"gpt_icon":0},{"id":"2490766878","title":"中信建投：長期仍舊看好CXO板塊發展潛力及成長空間","url":"https://stock-news.laohu8.com/highlight/detail?id=2490766878","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490766878?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 07:37","pubTimestamp":1733701030,"startTime":"0","endTime":"0","summary":"每经AI快讯，中信建投研报表示，23年底以来海外投融资逐渐恢复，下游需求维持向好，国内投融资底部趋稳，下游需求仍有待恢复。受益于国内CXO产业链的全面以及竞争力的领先，行业受地缘政治影响目前较为有限。国内临床前及临床CRO价格趋稳，经营趋势有望逐渐向上。CDMO企业商业化需求稳定，大订单影响24Q4开始已经消除。近年...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OxFHgZTIE_4amIsQWGj6cFYC_JrfTmz34Qvva7JdKknroAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OxFHgZTIE_4amIsQWGj6cFYC_JrfTmz34Qvva7JdKknroAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241209A013HC00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241209A013HC00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["CXO"],"gpt_icon":0},{"id":"2489773659","title":"久旱逢甘霖！CXO大舉反攻，醫療器械同步活躍，醫療ETF（512170）單週累漲3.23%，大幅跑贏市場！","url":"https://stock-news.laohu8.com/highlight/detail?id=2489773659","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489773659?lang=zh_tw&edition=fundamental","pubTime":"2024-12-08 20:52","pubTimestamp":1733662320,"startTime":"0","endTime":"0","summary":"周五，医疗久违爆发！267亿体量顶流医疗ETF早盘持续拉升，午后维持高位，盘中一度冲击4%，场内收涨3.23%，跑赢逾7成成份股！场内人气爆棚，全天成交9.18亿元，较前一日激增186%！　　值得关注的是，医疗ETF放量大涨，场内几乎全天溢价交易，显示买盘资金尤为旺盛，当前时点资金或对医疗后市表现较有信心。医疗器械股表现同样亮眼，奕瑞科技涨6.7%，华大智造涨5.11%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2024-12-08/doc-incyufem0340484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159883","BK1100","159828","BK1583","CXO","09996","09997","512170","BK1222","BK1574"],"gpt_icon":0},{"id":"2489528601","title":"【觀察】CXO龍頭漲超9%，美國生物安全法案妥協了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2489528601","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489528601?lang=zh_tw&edition=fundamental","pubTime":"2024-12-06 19:58","pubTimestamp":1733486306,"startTime":"0","endTime":"0","summary":"12月6日，CXO概念、CRO概念股集体飙涨。其中，药明康德（603259.SH）大涨7.41%，华大基因（300676.SZ）、华大智造（688114.SH）均上涨，港股的药明康德（02359.HK）更是涨超9%，药明生物（02269.HK）上涨5.47%。","market":"us","thumbnail":"https://images.finet.hk/photoLib/title/202412_1/9e7c25cc-536f-4dfc-9a58-fb60d020f3ee.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202412_1/9e7c25cc-536f-4dfc-9a58-fb60d020f3ee.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/6752e6e2bde0b34bf1749162","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["CXO"],"gpt_icon":0},{"id":"2489405567","title":"【港股收評】三大指數齊走高，恆科漲超2%！CXO成“領漲先鋒”","url":"https://stock-news.laohu8.com/highlight/detail?id=2489405567","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489405567?lang=zh_tw&edition=fundamental","pubTime":"2024-12-06 16:47","pubTimestamp":1733474878,"startTime":"0","endTime":"0","summary":"12月6日，港股三大指数集体冲高。截至收盘，恒生指数涨1.56%，国企指数涨1.75%，恒生科技指数涨2.16%。","market":"hk","thumbnail":"https://images.finet.hk/photoLib/title/202412_1/6f392deb-593b-4eb2-82c0-603356014f5f.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202412_1/6f392deb-593b-4eb2-82c0-603356014f5f.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/6752ba3ebde0b34bf174915e","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["YANG","07226","CXO","HSTECH","HSCEI"],"gpt_icon":0},{"id":"2489470997","title":"港股收盤，恒指收漲1.56%，科指收漲2.16%。CXO概念股走勢強勁，藥明康德(02359.HK)收漲約9%，藥明生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2489470997","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489470997?lang=zh_tw&edition=fundamental","pubTime":"2024-12-06 16:08","pubTimestamp":1733472513,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1521","LU0516423174.USD","LU1997245177.USD","MHImain","BK7095","LU0456846285.SGD","CXO.AU","LU2488822045.USD","LU1242518931.SGD","BK7504","07226","HSImain","BK0216","513600","LU2242644610.SGD","02359","LU0307460666.USD","LU0043850808.USD","LU0516422952.EUR","LU1242518857.USD","YANG","LU0572944931.SGD","LU0856984785.SGD","LU2039709279.SGD","HSTECH","CXO","LU0359202008.SGD","LU0456842615.SGD","LU0051755006.USD","02269","HSI","HHImain","SG9999002463.SGD","LU0588546209.SGD","00020","80020","HSCEI","LU1688375341.USD","LU2125910500.SGD","LU0140636845.USD","LU0326950275.SGD","LU0823426308.USD","02833","LU1720050803.USD","BK1576","BK1109","MCHmain","603259","LU0348825331.USD","LU0327786744.USD"],"gpt_icon":0},{"id":"2489475355","title":"醫療大反攻！CXO集體飆升，巨頭藥明康德漲逾8%，醫療ETF（512170）放量摸高4%！","url":"https://stock-news.laohu8.com/highlight/detail?id=2489475355","media":"市场资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489475355?lang=zh_tw&edition=fundamental","pubTime":"2024-12-06 13:26","pubTimestamp":1733462760,"startTime":"0","endTime":"0","summary":"医疗板块今日崛起！CXO午前接棒医疗器械涨势，龙头股集体飙升，巨头药明康德涨超8%，博腾股份涨超10%，昭衍新药、康龙化成涨超7%。　　A股顶流医疗ETF持续走高，盘中一度涨超4%，现涨逾3.5%，场内急速放量，实时成交额超7.2亿元，已是昨日全天成交额的2倍有余。市场分析人士指出，伴随降息预期升温，海外研发需求回升，CXO海外订单有望进一步恢复。在此背景下，业内认为，随着国内创新药研发需求持续攀升，CXO企业有望维持高景气度。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2024-12-06/doc-incypaar2096691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02359","CXO","BK1583","BK1141","LU2242644610.SGD","LU2125910500.SGD","LU2488822045.USD","LU1997245094.SGD","512170","603259","LU0708995583.HKD","LU2045819591.USD","BK0216","159828","LU0052750758.USD","LU0320764599.SGD","LU1046422090.SGD","159891","LU1997245177.USD","LU0456842615.SGD","BK1576"],"gpt_icon":0},{"id":"2489424033","title":"港股午評：恒生指數漲1.4%，恒生科技指數漲1.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489424033","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489424033?lang=zh_tw&edition=fundamental","pubTime":"2024-12-06 12:02","pubTimestamp":1733457743,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["00268","LU0348735423.USD","02359","BK7504","BK7095","603259","HSCEI","LU0326950275.SGD","LU1242518931.SGD","MHImain","SG9999002463.SGD","LU0516422440.USD","CXO","02269","LU2039709279.SGD","LU2488822045.USD","03086","02833","00020","BK1576","LU0823426308.USD","CXO.AU","HSI","LU0181495838.USD","BK1610","BK1521","LU0140636845.USD","BK1517","LU0327786744.USD","TTTN","BK1583","LU1046422090.SGD","YANG","LU0359201612.USD","LU0307460666.USD","80020","LU0979878070.USD","BK1607","LU0320764599.SGD","LU0417516902.SGD","LU2125910500.SGD","07226","LU0456846285.SGD","LU1720050803.USD","HHImain","BK1526","MCHmain","HSTECH","513600","HSImain"],"gpt_icon":0},{"id":"2489292074","title":"A股午評：滬指放量漲1.23% 保險股大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2489292074","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489292074?lang=zh_tw&edition=fundamental","pubTime":"2024-12-06 11:35","pubTimestamp":1733456101,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["000001.SH","510050","159982","399006","01336","BK0061","LU0287142896.SGD","601336","YXI","BK0218","BK0077","BK1184","BK0101","510030","CNmain","BK0183","BK7095","LU0307460666.USD","BK0066","300197","BK0163","BK0259","159667","LU0588546209.SGD","CXO.AU","300024","BK1584","399001","SG9999012736.USD","BK0130","LU1046422090.SGD","512550","BK0012","000300.SH","BK0073","601628","BK0122","SG9999012744.USD","000627","000016.SH","399300","BK0028","FXP","CXO","XPP","159526","BK0089","300071","BK0196","02628"],"gpt_icon":0},{"id":"2489253824","title":"港股CXO概念股震盪走高，藥明康德漲超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489253824","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489253824?lang=zh_tw&edition=fundamental","pubTime":"2024-12-06 10:09","pubTimestamp":1733450984,"startTime":"0","endTime":"0","summary":"每经AI快讯，港股CXO概念股震荡走高，药明康德涨超5%，药明生物涨超4%，康龙化成、凯莱英、金斯瑞生物科技跟涨。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202412063261211994.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412063261211994.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1046422090.SGD","LU0708995583.HKD","LU0052750758.USD","BK1583","HSCEI","CXO","BK1141","HSTECH","02359","LU0320764599.SGD","BK1576","LU2045819591.USD","YANG","LU2125910500.SGD","LU2242644610.SGD","07226"],"gpt_icon":0},{"id":"2486046547","title":"【券商聚焦】西南證券指CXO行業收入逐季回升 板塊悲觀預期修復在即","url":"https://stock-news.laohu8.com/highlight/detail?id=2486046547","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486046547?lang=zh_tw&edition=fundamental","pubTime":"2024-11-26 14:37","pubTimestamp":1732603072,"startTime":"0","endTime":"0","summary":"金吾财讯 | 西南证券发研报指，2024Q1-3CXO行业收入逐季回升，但利润整体仍有承压。分季度看，选取的20家CXO企业24Q3收入为226.1亿元；归母净利润35.9亿元；扣非归母净利润增速为-31.6%。该行续指，短期维度看，商业化订单持续消化，CDMO表观业绩承压；海外成熟CXO临床管线稳步推进，临床前需求仍有待修复。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1948420","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK0028","600369","BK0276","CXO","BK0188","BK0183"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":68,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CXO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-01-19","symbol":"CXO","reason":null,"defaultRemindTime":1611066600000,"announcedDate":"2021-01-14","type":"delisting","dateTimestamp":1611032400000},{"market":"US","date":"2020-11-05","symbol":"CXO","amount":0.2,"defaultRemindTime":1604586600000,"name":"康休","payableDate":"2020-11-06","currency":"USD","type":"dividend","dateTimestamp":1604552400000},{"market":"US","date":"2020-10-27","symbol":"CXO","fiscalQuarterEnding":"2020/09","expectedEps":1.14,"name":null,"time":"盤後","type":"earning","dateTimestamp":1603771200000,"reportTimeType":"post","actualEps":1.43},{"market":"US","date":"2020-08-06","symbol":"CXO","amount":0.2,"defaultRemindTime":1596720600000,"name":"康休","payableDate":"2020-08-07","currency":"USD","type":"dividend","dateTimestamp":1596686400000},{"market":"US","date":"2020-07-29","symbol":"CXO","fiscalQuarterEnding":"2020/06","expectedEps":0.33,"name":null,"time":"盤後","type":"earning","dateTimestamp":1595995200000,"reportTimeType":"post","actualEps":1.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CXO\",market:\"US\",,,undefined,":[{"executeDate":"2019-02-28","recordDate":null,"paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2019-05-09","recordDate":"2019-05-10","paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2019-08-08","recordDate":"2019-08-09","paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2019-11-07","recordDate":"2019-11-08","paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2020-02-27","recordDate":"2020-02-28","paymentDate":null,"value":0.2,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CXO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CXO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CXO","date":"2021-01-15","current":-1.325388,"percent":0.244996,"low":-22.831021,"twenty":-14.937462,"median":17.448879,"eighty":43.624979,"high":142.858816,"avg":25.025998,"sd":38.430736,"marketCap":13577273687},"quantilePoints":[{"date":"2020-04-17","current":-14.382708,"twenty":-14.693919,"median":33.652944,"eighty":50.675163,"marketCap":10139808865},{"date":"2020-04-24","current":-14.701154,"twenty":-14.719228,"median":33.451617,"eighty":50.252118,"marketCap":10364313682},{"date":"2020-05-01","current":-1.19246,"twenty":-14.900412,"median":33.010351,"eighty":49.874618,"marketCap":11074376079},{"date":"2020-05-08","current":-1.232608,"twenty":-14.900412,"median":29.923023,"eighty":49.729928,"marketCap":11447230976},{"date":"2020-05-15","current":-1.140541,"twenty":-14.900412,"median":28.505604,"eighty":49.729928,"marketCap":10592202468},{"date":"2020-05-22","current":-1.173542,"twenty":-14.900412,"median":27.9469,"eighty":49.729928,"marketCap":10898685290},{"date":"2020-05-29","current":-1.146006,"twenty":-14.900412,"median":27.733111,"eighty":49.729928,"marketCap":10642957585},{"date":"2020-06-05","current":-1.476649,"twenty":-14.900412,"median":27.185707,"eighty":49.729928,"marketCap":13713642157},{"date":"2020-06-12","current":-1.219155,"twenty":-14.900412,"median":26.906303,"eighty":49.729928,"marketCap":11322295304},{"date":"2020-06-19","current":-1.166606,"twenty":-14.900412,"median":26.678555,"eighty":49.729928,"marketCap":10834265334},{"date":"2020-06-26","current":-1.057302,"twenty":-14.900412,"median":26.223249,"eighty":49.729928,"marketCap":9819162996},{"date":"2020-07-02","current":-1.081895,"twenty":-14.900412,"median":26.100817,"eighty":49.729928,"marketCap":10047561022},{"date":"2020-07-10","current":-1.035021,"twenty":-14.900412,"median":25.811921,"eighty":49.729928,"marketCap":9612238289},{"date":"2020-07-17","current":-1.060245,"twenty":-14.900412,"median":25.495623,"eighty":49.729928,"marketCap":9846492674},{"date":"2020-07-24","current":-1.123725,"twenty":-14.900412,"median":25.400075,"eighty":49.729928,"marketCap":10436032878},{"date":"2020-07-31","current":-1.066588,"twenty":-14.900412,"median":25.179654,"eighty":49.536695,"marketCap":10265909235},{"date":"2020-08-07","current":-1.040806,"twenty":-14.900412,"median":24.527679,"eighty":48.902121,"marketCap":10017761067},{"date":"2020-08-14","current":-1.040603,"twenty":-14.900412,"median":24.088548,"eighty":48.654643,"marketCap":10015807145},{"date":"2020-08-21","current":-0.984371,"twenty":-14.900412,"median":23.757593,"eighty":48.04925,"marketCap":9474570590},{"date":"2020-08-28","current":-1.060904,"twenty":-14.900412,"median":23.237709,"eighty":48.005982,"marketCap":10211199403},{"date":"2020-09-04","current":-1.02822,"twenty":-14.900412,"median":22.879248,"eighty":47.833642,"marketCap":9896617867},{"date":"2020-09-11","current":-0.919815,"twenty":-14.900412,"median":22.710048,"eighty":47.357651,"marketCap":8853223209},{"date":"2020-09-18","current":-0.976251,"twenty":-14.900412,"median":22.487665,"eighty":46.705482,"marketCap":9396413687},{"date":"2020-09-25","current":-0.887335,"twenty":-14.900412,"median":22.044459,"eighty":45.673114,"marketCap":8540595597},{"date":"2020-10-02","current":-0.874342,"twenty":-14.900412,"median":21.695329,"eighty":45.308472,"marketCap":8415544552},{"date":"2020-10-09","current":-0.914131,"twenty":-14.900412,"median":21.325904,"eighty":45.001416,"marketCap":8798513377},{"date":"2020-10-16","current":-0.986604,"twenty":-14.900412,"median":20.472618,"eighty":44.616144,"marketCap":9496063738},{"date":"2020-10-23","current":-0.951552,"twenty":-14.900412,"median":20.050952,"eighty":44.013784,"marketCap":9158686969},{"date":"2020-10-30","current":-0.788207,"twenty":-14.900412,"median":19.603963,"eighty":43.678027,"marketCap":8074392990},{"date":"2020-11-06","current":-0.804917,"twenty":-14.900412,"median":19.294145,"eighty":43.599353,"marketCap":8245567787},{"date":"2020-11-13","current":-0.972584,"twenty":-14.900412,"median":18.943416,"eighty":43.599353,"marketCap":9963151264},{"date":"2020-11-20","current":-1.090882,"twenty":-14.900412,"median":18.315824,"eighty":43.599353,"marketCap":11174991021},{"date":"2020-11-27","current":-1.177658,"twenty":-14.900412,"median":18.027808,"eighty":43.599353,"marketCap":12063932866},{"date":"2020-12-04","current":-1.22361,"twenty":-14.900412,"median":17.915245,"eighty":43.599353,"marketCap":12534663558},{"date":"2020-12-11","current":-1.201394,"twenty":-14.900412,"median":17.827972,"eighty":43.599353,"marketCap":12307078885},{"date":"2020-12-17","current":-1.169683,"twenty":-14.906009,"median":17.756409,"eighty":43.604534,"marketCap":11982235804},{"date":"2020-12-24","current":-1.091261,"twenty":-14.911606,"median":17.634394,"eighty":43.609716,"marketCap":11178881358},{"date":"2020-12-31","current":-1.106262,"twenty":-14.920934,"median":17.601937,"eighty":43.610988,"marketCap":11332549641},{"date":"2021-01-08","current":-1.237472,"twenty":-14.937462,"median":17.527755,"eighty":43.624979,"marketCap":12676660833},{"date":"2021-01-15","current":-1.325388,"twenty":-14.937462,"median":17.448879,"eighty":43.624979,"marketCap":13577273687}],"updateTime":1744783113146}}}